Outbreak of candidemia caused by fluconazole resistant Candida parapsilosis strains in an intensive care unit

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Pinhati, Henrique Marconi Sampaio ^a   Casulari, Luiz Augusto ^a   Souza, Ana Carolina Remondi ^b   Siqueira, Ricardo Andreotti ^b   Damasceno, Camila Maria Gomes ^a   Colombo, Arnaldo Lopes ^b  

^a Ed América Office Tower ^*  (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antifungal treatment; Candida sp; Candidemia; Fluconazole resistance

Indexed keywords

FLUCONAZOLE; ANTIFUNGAL AGENT;

ADULT; AGED; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA PARAPSILOSIS; CANDIDEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; FEMALE; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MALE; MOLECULAR TYPING; NONHUMAN; RISK FACTOR; TERTIARY CARE CENTER; BRAZIL; CANDIDA; CROSS INFECTION; EPIDEMIC; HOSPITAL; INCIDENCE; MICROBIOLOGY; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BRAZIL; CANDIDA; CANDIDEMIA; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DISEASE OUTBREAKS; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HOSPITALS; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MOLECULAR TYPING; RISK FACTORS; YOUNG ADULT;

EID: 84983541264     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1767-9     Document Type: Article

References (36)

1. Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis. 2010;14:e954-66.
2. Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). Int J Antimicrob Agents. 2011;38:65-9.
3. Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014;10:95-105.
4. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133-63.
5. Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS One. 2013;8:e59373.
6. Moretti ML, Trabasso P, Lyra L, Fagnani R, Resende MR, de Oliveira Cardoso LG, et al. Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil. Med Mycol. 2013;51:225-30.
7. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, et al. Epidemiology of Candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006;44:2816-23.
8. Heimann SM, Cornely OA, Wisplinghoff H, Kochanek M, Stippel D, Padosch SA, et al. Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole. Eur J Clin Microbiol Infect Dis. 2014;34:331-8.
9. Falagas ME, Apostolou KE, Pappas VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis. 2006;25:419-25.
10. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ellis D, Tullio V, et al. Results from the Artemis DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to Fluconazole and Voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol. 2010;48:1366-77.
11. Hinrichsen SL, Falcão É, Vilella TAS, Colombo AL, Nucci M, Moura L, et al. Candidemia in a tertiary hospital in northeastern Brazil. Rev Soc Bras Med Trop Agosto De. 2008;41:394-8.
12. Morii D, Seki M, Binongo JN, Ban R, Kobayashi A, Sata M, Hashimoto S, Shimizu J, Morita S, Tomono K. Distribution of Candida species isolated from blood cultures in hospitals in Osaka. Japan J Infect Chemother. 2014;20:558-62.
13. Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, et al. Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) Registry 2004-2008. PLoS One. 2014;9:e101510.
14. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. ClinMicrobiol Infect. 2012;18:19-37.
15. Colombo AL, Guimarães T, Camargo LF, Richtmann R, de Queiroz-Telles F, Salles MJ, et al. Brazilian guidelines for the management of candidiasis - a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical. Braz J Infect Dis. 2013;17:283-312.
16. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503-35.
17. Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and Mold isolates collected from 2010 to 2011: application of New CLSI clinical breakpoints and epidemiological Cutoff values for characterization of geographic and temporal trends of antifungal resistance. J ClinMicrobiol. 2013;51:2571-81.
18. Souza ACR, Fuchs BB, Pinhati HMS, Siqueira RA, Hagen F, Meis JF, et al. Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae. Antimicrob Agents Chemother. 2015;59(10):6581-7.
19. Jain P, Khan ZK, Bhattacharya E, Ranade SA. Variation in random amplified polymorphic DNA (RAPD) profiles specific to fluconazole-resistant and -sensitive strains of Candida albicans. Diagn Microbiol Infect Dis. 2001;41:113-9.
20. Souza ACR, Ferreira RC, Gonçalves SS, Quindós G, Eraso E, Bizerra FC, et al. Accurate identification of Candida parapsilosis (sensu lato) by use of mitochondrial DNA and real-Time PCR. J Clin Microbiol. 2012;50:2310-4.
21. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-3rd ed. document M27-A3. Wayne: CLSI; 2008.
22. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. 4th informational supplement.document M27-S4. Wayne: CLSI; 2012.
23. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21.
24. Tumbarello M, Posteraro B, Trecarichi EM, Fiori B, Rossi M, Porta R, et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol. 2007;45:1843-50.
25. Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis. 2012;55:1352-61.
26. Pfaller MA, Jones RN, Castanheira M. Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006-2011. Mycoses. 2014;57:602-11.
27. Arendrup MC, Dzajic E, Jensen RH, Johansen HK, Kjældgaard P, Knudsen JD, et al. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a Nationwide fungaemia surveillance programme. Clin Microbiol Infect. 2013;19:E343-53.
28. Minea B, Nastasa V, Moraru RF, Kolecka A, Flonta MM, Marincu I, et al. Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study. Eur J Clin Microbiol Infect Dis. 2015;34:367-83.
29. Silva AP, Miranda IM, Lisboa C, Pina-Vaz C, Rodrigues AG. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. Metapsilosis in a tertiary care hospital. J Clin Microbiol. 2009;47:2392-7.
30. Gonçalves SS, Amorim CS, Nucci M, Padovan ACB, Briones MRS, Melo ASA, et al. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clin Microbiol Infect. 2010;16:885-7.
31. Ruiz LS, Khouri S, Hahn RC, da Silva EG, de Oliveira VK, Gandra RF, et al. Candidemia by species of the Candida parapsilosis complex in children's hospital: prevalence, biofilm production and antifungal susceptibility. Mycopathologia. 2013;175:231-9.
32. Bonfietti LX, Martins Mdos A, Szeszs MW, Pukiskas SB, Purisco SU, Pimentel FC, et al. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates. J Med Microbiol. 2012;61:1003-8.
33. Trabasso P, Matsuzawa T, Fagnani R, Muraosa Y, Tominaga K, Resende MR, et al. Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species. Mycopathologia. 2015;179:53-62.
34. Cantón E, Pemán J, Quindós G, Eraso E, Miranda-Zapico I, Álvarez M, et al. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia. Antimicrob Agents Chemother. 2011;55:5590-6.
35. Feng X, Ling B, Yang G, Yu X, Ren D, Yao Z. Prevalence and distribution profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis responsible for superficial candidiasis in a Chinese university hospital. Mycopathologia. 2012;173:229-34.
36. Trofa D, Gácser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008;21:606-25.